Anaergia says it has entered into a definitive purchase agreement and divested its Charlotte, North Carolina, bioenergy asset and its Rhode Island bioenergy-facility interests as it concentrates on other growth opportunities.

Published by Allstream Insiders

Allstream Insiders Summary

Anaergia has announced a definitive Master Purchase Agreement involving the divestiture of two non-core U.S. bioenergy holdings: the Charlotte Bioenergy Facility in Charlotte, North Carolina, and interests in the Rhode Island Bioenergy Facility in Johnston, Rhode Island. According to Anaergia’s October 1, 2026, release, the buyer has acquired the Charlotte facility and 100% interests in both the Rhode Island Bioenergy Facility HoldCo and Rhode Island Bioenergy Facility entities.

The release describes the transaction as a portfolio-concentration step. It says the Charlotte facility had not been operating and that the Rhode Island facility had been operating below the company’s expected capacity. These are company-reported operating-status statements; the announcement does not provide current production data, facility capacities, restart plans or an independent assessment of either asset.

The announcement does not identify a new development project, facility upgrade, construction program, anaerobic-digestion expansion, renewable-natural-gas contract, contractor award or operating transition plan for the two assets. It should therefore be read as an asset-divestiture update, not as an announcement that either facility is entering development or resuming operations.

Anaergia Bioenergy Divestiture at a Glance

What assets are included in the transaction?

The announced transaction covers the Charlotte Bioenergy Facility and Anaergia’s Rhode Island bioenergy-facility interests. Anaergia said the buyer acquired the Charlotte asset as well as 100% interests in Rhode Island Bioenergy Facility HoldCo, LLC and Rhode Island Bioenergy Facility, LLC.

The release identifies the locations as Charlotte, North Carolina, and Johnston, Rhode Island. It does not disclose the facilities’ feedstocks, process configuration, nameplate capacity, actual output, customer contracts, operating permits or equipment condition. Those details should not be inferred from the facilities’ bioenergy descriptions alone.

Has the divestiture been completed?

Anaergia’s October 1 release announces entry into a definitive Master Purchase Agreement and also states that the buyer has acquired the specified assets and interests. The company further said it sold the Charlotte facility and deconsolidated its interest in the Rhode Island facility.

The article reports that status exactly as Anaergia described it. The announcement does not provide a separate closing date, identify the buyer by name in the supplied transaction description, or disclose post-transaction operating responsibilities for the facilities.

What did Anaergia report about operations at the two facilities?

Anaergia said the Charlotte facility had not been operating and the Rhode Island facility had been operating below its expected capacity. The company presented those statements as part of its rationale for addressing non-core assets.

The announcement provides no independent production records, current operating data, root-cause analysis, remediation plan or future operating forecast. It therefore does not establish whether either facility will be restarted, modified, expanded, idled or operated differently by the buyer.

What has not been announced?

The October 1 release does not announce a capital project for either facility. It does not identify a technology upgrade, engineering study, environmental remediation scope, construction contract, anaerobic-digestion modification, biomethane or renewable-natural-gas agreement, contractor, supplier or operating schedule.

The announcement also does not state the buyer’s strategy for either facility. No future capacity, production, employment, permit, commissioning or commercial-start outcome should be assumed from Anaergia’s divestiture announcement.

Allstream perspective: portfolio divestiture with no new facility-development scope

Anaergia’s announcement reports an ownership and portfolio change affecting two U.S. bioenergy assets. While the release provides operating-status context reported by Anaergia, it does not establish a forward project path for either the Charlotte or Rhode Island facility.

For renewable-energy and bioenergy market participants, the next decision-useful disclosures would be a clearly identified buyer, transaction closing documentation, post-transaction operating plans, facility-capacity information, permits, project authorizations, engineering or construction scope, commercial contracts and service-provider awards. Until then, the transaction should be tracked as a divestiture—not as a new project opportunity.